Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Aoki

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Transfusion|September 1, 1989
Lyme disease--another transfusion risk?S K Aoki, P V Holland
Journal of Bacteriology|January 7, 2009
Contact-dependent growth inhibition causes reversible metabolic downregulation in Escherichia coliS K Aoki, J S Webb, B A Braaten, et al.
Journal of Viral Hepatitis|January 1, 1994
Evidence that use of a second-generation hepatitis C antibody assay prevents additional cases of transfusion-transmitted hepatitisS K Aoki, I K Kuramoto, S Anderson, et al.
Transfusion|May 1, 1993
Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccineS K Aoki, D Finegold, I K Kuramoto, et al.
Blood|August 1, 1993
Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis CS K Aoki, P V Holland, L P Fernando, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Transfusion|September 1, 1989
Lyme disease--another transfusion risk?S K Aoki, P V Holland
Journal of Bacteriology|January 7, 2009
Contact-dependent growth inhibition causes reversible metabolic downregulation in Escherichia coliS K Aoki, J S Webb, B A Braaten, et al.
Journal of Viral Hepatitis|January 1, 1994
Evidence that use of a second-generation hepatitis C antibody assay prevents additional cases of transfusion-transmitted hepatitisS K Aoki, I K Kuramoto, S Anderson, et al.
Transfusion|May 1, 1993
Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccineS K Aoki, D Finegold, I K Kuramoto, et al.
Blood|August 1, 1993
Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis CS K Aoki, P V Holland, L P Fernando, et al.
Pageof 1